Micropos Medical AB

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0002834507
SEK
1.23
-0.15 (-10.58%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Micropos Medical AB stock-summary
stock-summary
Micropos Medical AB
Pharmaceuticals & Biotechnology
Micropos Medical publ AB is a Sweden-based company engaged in the development of medical devices for high precision four dimensional (4D) radiotherapy. The Company’s first product is RayPilot, an electromagnetic positioning system that enables real time information of the position of the prostate. The system works as an add-on to existing linear accelerators and enables control of a region of interest (ROI) position throughout every radiotherapy session. It consists of RayPilot receiving system, RayPilot transmitter that is placed in the ROI, and RayPilot software. The Company markets its products through sales offices in the Nordic countries, a network of distributors in Europe, the United States and Asia, and through Business to Business (B2B) partnerships with T ex Elekta and Varian & Siemens.
Company Coordinates stock-summary
Company Details
Adolf Edelsvards Gata 11 , GOETEBORG None : 41451
stock-summary
Tel: 46 31 772814646
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Ove Mattsson
Chairman of the Board
Mr. Torben Joergensen
Director
Mr. Olof Sanden
Director
Mr. Tom Sundelin
Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
3 Million
(Quarterly Results - Jun 2025)
Net Profit:
-4 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK Million (Micro Cap)

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.83

stock-summary
Return on Equity

-101.95%

stock-summary
Price to Book

0.00